Analyst Ratings for bluebird bio (BLUE) [Neutrals]

BLUE Rating Summary

BLUE Price Target Summary

* Over Last 12-Mos
  |   Expand Research on BLUE
Overall Rating: NEUTRAL   Rating Trend: =   Avg. $ Target: $48.75 (+66.9%) * Over Last 12-Mos
Rating Score: 5 / 10   Percentile Rank: 50%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
2/17/2021 JPMorgan Cory Kasimov Downgrade Neutral
(Overweight)
39.00
(76.00)
45.76
(29.21)
-36.17% Details
2/16/2021 Oppenheimer Mark Breidenbach Downgrade Perform
(Outperform)
N/A
(N/A)
45.76
(29.21)
-36.17% Details
Like BLUE Ratings? Also take a look at BMY, EH, FUBO, JT

BLUE Ratings News